Copanlisib With Ibrutinib for Patients With Recurrent/ Refractory Primary Central Nervous System Lymphoma (PCNSL)
Clinical trial NCT03581942 · COMPLETED
Trial details
- NCT number
- NCT03581942
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-23
- Primary completion
- 2026-02-05
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.